Search Results - hua+linda+cai

13 Results Sort By:
Gsx1 GENE THERAPY TO TREAT SPINAL CORD INJURY
​ Gsx1 treatment promotes recovery of locomotion function in injured mice. Invention Summary: Spinal cord injury (SCI) can lead to permanent disruption of nervous system function. There is no effective treatment for promoting recovery of motor function after SCI currently available on the market. Previous research on SCI treatment focused on...
Published: 6/12/2023   |   Inventor(s): Li Cai, Misaal Patel, Lisa Lyu
Keywords(s): Spinal Cord
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics, Technology Classifications > Gene Therapy, Technology Classifications > CNS Disorder
Self-neutralizing air-breathing thruster and method of neutralization
An ion-engine is the cutting edge for atmospheric air-breathing engines. The technology depends on ionizing and neutralizing atmospheric air particles which create thrust. This unique possibility makes it an ideal choice for very-low-orbit satellites. Very- low-orbit satellite capabilities have benefits such as higher resolution for images, weight...
Published: 7/30/2024   |   Inventor(s): Michael Keidar, Anmol Taploo, Li Lin
Keywords(s):  
Category(s): Technology Classifications > Computers Electronics & Software, Technology Classifications > Computers Electronics & Software > Aviation, Technology Classifications > Industrial or Consumer Tech > Energy Infrastructure and Environment, Technology Classifications > Industrial or Consumer Tech > Industrial Manufacturing
Non-Invasive Plasma Discharge Tube Device for Treating Brain Tumors
Treating brain tumors, like glioblastoma, is challenging. Current glioblastoma drugs, Rapamycin and Temozolomide (TMZ), generally only extend life for a matter of months, are not very effective in treating recurring tumors, and have significant clinical toxicity. A novel Plasma Discharge Tube (PDT) device has the potential to be more effective and less...
Published: 7/30/2024   |   Inventor(s): Michael Keidar, Li Lin, Vikas Soni, Xiaoliang Yao, Dayun Yan, Jonathan Sherman
Keywords(s):  
Category(s): Technology Classifications > Medical Devices, Technology Classifications > Medical Devices > Surgical
PMU-Embedded Analytics for Online Event Detection and Classification in Power Grids
The energy requirement of the world is increasing exponentially every year. With the power demand sites concentrated in the region with the highest population density, energy production sites must be located remotely. This isolation requires lengthy and complicated grids to be designed and manufactured to transmit power over long distances. Grid failures...
Published: 7/30/2024   |   Inventor(s): Payman Dehghanian, Shiyuan Wang, Li Li
Keywords(s):  
Category(s): Technology Classifications > Industrial or Consumer Tech > Energy Infrastructure and Environment
Cold atmospheric plasma-stimulated media for treating cancers
For successful cancer therapy, the most important aspect is selective eradication of cancer cells without damaging healthy cells. Cancer cells and normal cells have different thresholds for tolerance of reactive oxygen species (ROS) and reactive nitrogen species (RNS) before cell death (apoptosis) is induced. Previously, GW researchers invented a cold...
Published: 7/30/2024   |   Inventor(s): Michael Keidar, Zhitong Chen, Xiaoqian Cheng, Li Lin
Keywords(s):  
Category(s): Technology Classifications > Therapeutics > Cells, Technology Classifications > Therapeutics
2021-189: NOVEL AND ROBUST COMBINATORY THERAPY FOR AORTIC ANEURYSMS
­SUMMARY: Researchers from UCLA’s Department of Anesthesiology have developed an oral combinatory therapy that holds enormous implications in healthcare for the complete attenuation of aneurysm formation. BACKGROUND: Aortic aneurysms are abnormal protrusions in the major blood vessels from the heart to the rest of the body. These protrusions...
Published: 7/19/2023   |   Inventor(s): Hua Linda Cai
Keywords(s):  
Category(s): Therapeutics > Cardiovascular, Therapeutics > Hematology
2020-472 MIRNA-192-5P INHIBITORS AS NOVEL DRUGS TREATING AORTIC ANEURYSMS
UCLA researchers in the Department of Anesthesiology have developed novel inhibitors of miRNA-192-5P for the treatment of abdominal aortic aneurysms. BACKGROUND: Abdominal aortic aneurysm (AAA) occurs when the lower part of the major vessel that distributes blood to the body, the aorta, becomes weakened and enlarged. A weakened andenlarged aorta may...
Published: 7/19/2023   |   Inventor(s): Hua Linda Cai
Keywords(s): Cardiovascular, Therapeutics & Vaccines
Category(s): Therapeutics > Cardiovascular
2019-728 NOVEL LIPID LOWERING, ANTI-ATHEROSCLEROSIS AND ANTI-OBESITY EFFECTS OF NETRIN-1
UCLA researchers in the Department of Anesthesiology have developed a novel and extremely robust lipid lowering, anti-atherosclerotic, and anti-obesity treatment with Netrin-1.BACKGROUND:Hyperlipidemia, an elevation of different forms of lipids in the bloodstream, is the most important risk factor for coronary heart disease, while causing many other...
Published: 9/5/2023   |   Inventor(s): Hua Linda Cai
Keywords(s): Cardiovascular, Hematology, Therapeutics & Vaccines
Category(s): Therapeutics > Cardiovascular, Therapeutics > Hematology
2018-858 NETRIN-1 PEPTIDES FOR THE TREATMENT OF PULMONARY HYPERTENSION
INTRO SENTENCE:UCLA researchers in the Department of Anesthesiology & Perioperative Medicine have developed a treatment for pulmonary hypertension. BACKGROUND:Pulmonary hypertension (PH) is a devastating cardiovascular “cancer” with increased vascular resistance in the lung and chronic failure of the right heart. Common symptoms include:...
Published: 7/19/2023   |   Inventor(s): Hua Linda Cai
Keywords(s): Cardiovascular, Therapeutics & Vaccines
Category(s): Therapeutics, Therapeutics > Cardiovascular
2014-526 SMALL NETRIN-1 DERIVED PEPTIDES FOR CARDIOPROTECTION
Netrin-1 Compounds as Post-MI and Post-Angioplasty Therapeutics as well as for Treating Renal and CNS Reperfusion InjurySUMMARYUCLA researchers have invented a method of decreasing myocardial injury and infarct size through the intravenous administration of the netrin-1 or netrin-1-derived peptides during a cardiac event. These agents have powerful...
Published: 7/19/2023   |   Inventor(s): Hua Linda Cai, Qiang Li
Keywords(s):  
Category(s): Therapeutics, Therapeutics > Cardiovascular
1 2